Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Helen Of Troy In Supplements; J&J Innovation; U.K. Ad Enforcement; CHPA Chairman-elect; Hispanic Consumer Health

This article was originally published in The Tan Sheet

Executive Summary

Helen Of Troy Acquires Supplement Firm; J&J eyes probiotics to skin, oral health and respiratory conditions; ASA rules on Danon Baby Nutrition ad; FDA continues to pursue tainted supplements; FDA warns about tainted bee pollen; CHPA names board chair-elect; and USP educates Hispanics about supplements.

You may also be interested in...

CHPA Agenda 2014: Monograph Reform, NSURE Progress

The Consumer Healthcare Products Association plans to tackle big tasks in 2014, including working with FDA to improve the monograph system, move the new Rx-to-OTC switch paradigm forward and determine quality metrics to help FDA better target inspections. The trade group also is looking for ways to ease pricing pressures and ensure quality does not suffer.

Regulatory News In Brief

Ortho Molecular supplement claims draw warning letter; FDA flags Global Source Management violations; Zi Xiu Tang bee pollen capsules recall follows FDA buzz; Wal-Born users eligible for refunds, FTC says; GAO endorses FDA comparability approach to food import safety.

J&J Sprouts Innovation Centers In Industry Hot Spots

In an effort to expand outreach to and interaction with innovation-rich communities, J&J creates four new regional innovation centers to act as scouts, dealmakers and alliance managers in Boston, California, London and Shanghai.


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts